MedPath

The Accuracy of Pediatric Air Test as a Non-invasive Atelectasis Diagnostic Tool

Not Applicable
Completed
Conditions
Lung Collapse
Pediatric Disorder
Atelectasis
Atelectasis Without Respiratory Distress Syndrome
Atelectases, Resorption
Air Test
Lung Diseases
Interventions
Diagnostic Test: Air test
Registration Number
NCT04506203
Lead Sponsor
Hospital Universitario La Paz
Brief Summary

HYPOTHESIS:

During anesthetic pre-oxygenation with high FiO2, pulmonary atelectasis occur, especially in patients \< 6 years old, where FRC and pulmonary closing volume may overlap. New borns and children \<1 year old are especially vulnerable.

OBJECTIVES:

1. Validate "air test" as a individualized and non-invasive diagnostic method of clinically significant atelectasis in pediatrics.

2. Determine what other factors contribute to atelectasis development in pediatrics

METHODS:

30 pediatric patients will be studied with ages ranged between 45 postconceptional weeks and16 years old.

Baseline SpO2 and lung ultrasound will be performed for each patient upon arrival at the operating theatre before preoxygenation with FiO2 of 1.0 SpO2 will be measured 15 min after intubation during a 5 min long "air test" trial (FiO2 0.25). lung collapse will be verified by lung ultrasound at the end of the 15 min trial. Lung collapse will be eventually granted upon lung US verification by a blind researcher.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
108
Inclusion Criteria
  • General anesthesia
  • Perioperative risk classification (ASA) I, II, III
  • Newborns (postconceptional age> 45 weeks) to 16 years
  • Need for oral / nasotracheal intubation
Exclusion Criteria
  • ASA > III
  • Basal SpO2 < 97% on air in supine position
  • Preoperative need for oxygen therapy and / or high-flow nasal cannulas
  • Expected Difficult airway
  • Presence of craniofacial disorders that may compromise ventilation
  • Hemodynamic instability and / or need for inotropics
  • History of untreated heart disease
  • Presence or history of pneumothorax
  • Presence of untreated congenital pulmonary disorders
  • Refusal to participate in the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Air testAir test-
Primary Outcome Measures
NameTimeMethod
Atelectasis incidence5 minutes

Assess incidence of SpO2 \< 97% 15 minutes after anesthesia induction during a 5 minutes long air test (FiO2 \< 0.25).

Accuracy of Pediatric Air test trial5 minutes

Assess incidence of lung collapse (hence atelectasis incidence) 15 minutes after anesthesia induction using an air test (FiO2 \< 0.25). Collapse blind validation using lung US

Secondary Outcome Measures
NameTimeMethod
Atelectasis severity5 minutes

Determine if there is any correlation between SpO2 values during air test and lung collapse, graded upon a validated severity lung collapse image score

Atelectasis risk factors assessment5 minutes

Determine if there occurs higher atelectasis incidence depending on age, sex, medical records, body weight index or type of surgery

Trial Locations

Locations (3)

Hospital Privado de Comunidad

🇦🇷

Córdoba, Argentina

Hospital Universitario La Paz

🇪🇸

Madrid, Spain

Hospital Universitario La Princesa

🇪🇸

Madrid, Spain

© Copyright 2025. All Rights Reserved by MedPath